Attached files

file filename
EX-10.1 - EX-10.1 - Dyne Therapeutics, Inc.d920854dex101.htm
EX-21.1 - EX-21.1 - Dyne Therapeutics, Inc.d920854dex211.htm
EX-10.20 - EX-10.20 - Dyne Therapeutics, Inc.d920854dex1020.htm
EX-10.19 - EX-10.19 - Dyne Therapeutics, Inc.d920854dex1019.htm
EX-10.18 - EX-10.18 - Dyne Therapeutics, Inc.d920854dex1018.htm
EX-10.17 - EX-10.17 - Dyne Therapeutics, Inc.d920854dex1017.htm
EX-10.16 - EX-10.16 - Dyne Therapeutics, Inc.d920854dex1016.htm
EX-10.15 - EX-10.15 - Dyne Therapeutics, Inc.d920854dex1015.htm
EX-10.14 - EX-10.14 - Dyne Therapeutics, Inc.d920854dex1014.htm
EX-10.13 - EX-10.13 - Dyne Therapeutics, Inc.d920854dex1013.htm
EX-10.12 - EX-10.12 - Dyne Therapeutics, Inc.d920854dex1012.htm
EX-10.11 - EX-10.11 - Dyne Therapeutics, Inc.d920854dex1011.htm
EX-10.10 - EX-10.10 - Dyne Therapeutics, Inc.d920854dex1010.htm
EX-10.9 - EX-10.9 - Dyne Therapeutics, Inc.d920854dex109.htm
EX-10.8 - EX-10.8 - Dyne Therapeutics, Inc.d920854dex108.htm
EX-10.7 - EX-10.7 - Dyne Therapeutics, Inc.d920854dex107.htm
EX-10.6 - EX-10.6 - Dyne Therapeutics, Inc.d920854dex106.htm
EX-10.5 - EX-10.5 - Dyne Therapeutics, Inc.d920854dex105.htm
EX-10.4 - EX-10.4 - Dyne Therapeutics, Inc.d920854dex104.htm
EX-10.3 - EX-10.3 - Dyne Therapeutics, Inc.d920854dex103.htm
EX-10.2 - EX-10.2 - Dyne Therapeutics, Inc.d920854dex102.htm
EX-4.2 - EX-4.2 - Dyne Therapeutics, Inc.d920854dex42.htm
EX-3.4 - EX-3.4 - Dyne Therapeutics, Inc.d920854dex34.htm
EX-3.3 - EX-3.3 - Dyne Therapeutics, Inc.d920854dex33.htm
EX-3.2 - EX-3.2 - Dyne Therapeutics, Inc.d920854dex32.htm
EX-3.1 - EX-3.1 - Dyne Therapeutics, Inc.d920854dex31.htm
S-1 - S-1 - Dyne Therapeutics, Inc.d920854ds1.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement on Form S-1 of our report dated July 23, 2020, relating to the financial statements of Dyne Therapeutics, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

August 25, 2020